PDHEX Performance — PGIM Target Date 2040 Fund, Class R2
Data updated: 2026-10-13
PDHEX returned +9.61% year to date and +17.96% over one year to Jul 2026. Annualised returns are +13.49% over 3 years and +7.72% over 5 years. The fund beat its Target-Date category average: $100 invested three years ago grew to $146, against $146 for the category, and to $118 over one year, against $116. Volatility over the past three years was 9.79% a year. In the 12 months to Jul 2026 the fund lost a net $10.1M, and assets reached $39.17M.
PDHEX Growth of $100
What $100 invested in PGIM Target Date 2040 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | PDHEX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $118 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $146 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $145 | $142 |
| Since data start (Aug 2019 – Jul 2026) | $194 | $186 |
PDHEX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +9.61% |
| 1 year | +17.96% |
| 3 years (annualised) | +13.49% |
| 5 years (annualised) | +7.72% |
PDHEX Annual Returns
Calendar-year total returns of PGIM Target Date 2040 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +9.61% |
| 2025 | +15.80% |
| 2024 | +11.69% |
| 2023 | +15.51% |
| 2022 | −14.79% |
| 2021 | +17.68% |
| 2020 | +10.44% |
| 2019 (Aug–Dec) | +6.98% |
PDHEX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.7% | +1.9% | −4.9% | +7.3% | +2.8% | +0.1% | −0.3% | — | — | — | — | — |
| 2025 | +2.6% | +0.1% | −2.6% | 0.0% | +3.8% | +3.4% | +0.3% | +2.7% | +2.3% | +1.3% | +0.8% | +0.4% |
| 2024 | 0.0% | +2.8% | +2.7% | −3.3% | +3.7% | +1.1% | +2.1% | +2.1% | +1.9% | −2.2% | +3.1% | −2.6% |
| 2023 | +6.1% | −2.9% | +1.9% | +0.8% | −1.6% | +4.6% | +2.8% | −2.1% | −3.6% | −2.6% | +7.2% | +4.7% |
| 2022 | −3.5% | −1.4% | +1.3% | −6.0% | +0.4% | −7.6% | +6.6% | −3.6% | −8.6% | +5.3% | +6.6% | −3.8% |
| 2021 | +0.1% | +2.4% | +2.9% | +3.8% | +1.4% | +0.8% | +1.2% | +1.6% | −3.2% | +4.0% | −2.0% | +3.8% |
| 2020 | −1.2% | −6.6% | −13.1% | +9.0% | +4.2% | +2.6% | +4.0% | +4.2% | −2.7% | −1.5% | +9.3% | +4.0% |
| 2019 | — | — | — | — | — | — | — | −1.6% | +1.8% | +2.1% | +2.0% | +2.6% |
PDHEX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 9.79%
- 3-year Sharpe ratio: 0.92 (vs 4.5% risk-free rate)
- Best month: +7.27% (Apr 2026)
- Worst month: −4.93% (Mar 2026)
PDHEX Fund Flows
Monthly money in and out of PGIM Target Date 2040 Fund, from SEC Form N-PORT.
- 12-month net flow: −$10.1M
- 12-month gross sales (incl. reinvestments): $8.7M
- Sales ÷ redemptions: 0.46×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $243K | $420K | −$177K |
| Jun 2026 | $1.1M | $133K | $987K |
| May 2026 | $263K | $2.4M | −$2.2M |
| Apr 2026 | $221K | $1.3M | −$1.1M |
| Mar 2026 | $575K | $10.6M | −$10.0M |
| Feb 2026 | $254K | $304K | −$50K |
| Jan 2026 | $277K | $568K | −$291K |
| Dec 2025 | $4.3M | $422K | $3.9M |
| Nov 2025 | $228K | $631K | −$403K |
| Oct 2025 | $601K | $414K | $188K |
| Sep 2025 | $386K | $525K | −$139K |
| Aug 2025 | $202K | $1.1M | −$858K |
PDHEX Assets Under Management
Net assets of PGIM Target Date 2040 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $39.17M |
| 2026-04-30 | $39.47M |
| 2026-01-30 | $49.28M |
| 2025-10-31 | $46.33M |
| 2025-07-31 | $44.27M |
| 2025-04-30 | $41.70M |
| 2025-01-31 | $43.10M |
| 2024-10-31 | $41.26M |
| 2024-07-31 | $40.77M |
| 2024-04-30 | $36.88M |
| 2024-01-31 | $36.26M |
| 2023-10-31 | $42.76M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.